论文部分内容阅读
目的:探讨并分析盐酸氟桂利嗪胶囊与尼莫地平片防治偏头痛的疗效。方法:选取2014年3月至2014年7月入住我院进行偏头痛治疗的76例患者,在征得患者及其家属同意的情况下,将其随机分为对照组与观察组各38例,对照组给予尼莫地平治疗治疗,观察组则给予盐酸氟桂利嗪胶囊,观察并比较两组患者的疗效。结果:经为其4个月的有效治疗后,对照组与观察组的治疗有效率分别为81.6%、89.5%,不良反应率为23.7%、13.2%,观察组均显著优于对照组,其比较差异具有统计学意义(P<0.05)。结论:两种药物在防治偏头痛方面均有一定的疗效,但,盐酸氟桂利嗪胶囊的防治疗效更为显著,值得在临床上推广及应用。
Objective: To investigate and analyze the efficacy of flunarizine hydrochloride capsules and nimodipine in prevention and treatment of migraine. Methods: From March 2014 to July 2014, 76 patients admitted to our hospital for migraine were randomly divided into control group and observation group (38 cases) with consent of patients and their families, The control group was treated with nimodipine, while the observation group was given flunarizine hydrochloride capsules. The curative effect of both groups was observed and compared. Results: After 4 months of effective treatment, the effective rates of the control group and the observation group were 81.6% and 89.5% respectively, and the adverse reactions were 23.7% and 13.2% respectively. The observation group was significantly better than the control group The difference was statistically significant (P <0.05). Conclusion: The two drugs have some curative effect in the prevention and treatment of migraine. However, Flunarizine Hydrochloride Capsule is more effective in preventing and treating migraine. It is worth to be popularized and applied clinically.